Latest / Skin Anarchy / Exosome Innovation and Preventative Skincare ft. AnteAGE

Transcript

Exosome Innovation and Preventative Skincare ft. AnteAGE · Skin Anarchy

0:02
SPEAKER_00: Hey guys, welcome back to Spin Anarchy.
0:04
SPEAKER_00: Today's episode is gonna dive really deep into the world of exosomes.
0:08
SPEAKER_00: We're interviewing a brand today that I think is doing exosomes in the right way.
0:14
SPEAKER_00: And I know there's a lot of hype right now in the skincare space about this specific technology and wanting to learn more about it and understanding what exosomes actually do when it comes to skincare.
0:24
SPEAKER_00: So what are the results we can expect?
0:26
SPEAKER_00: All of those kind of questions are coming up from you guys for us.
0:30
SPEAKER_00: So I'm very excited to have this opportunity to host a brand that's leading the way here, you know, in this space.
0:34
SPEAKER_00: So without further ado, I'd love to introduce you guys to Blenna LaRue.
0:38
SPEAKER_00: She is an award-winning aesthetic sales and education leader, and she's here representing Anti-H MD.
0:44
SPEAKER_00: Welcome, Blenna.
0:45
SPEAKER_00: I'm so excited to interview you.
0:46
SPEAKER_01: Hi, thank you.
0:47
SPEAKER_01: So happy to be here.
0:49
SPEAKER_00: Yeah, I'm excited to chat and dive in.
0:51
SPEAKER_00: You know, I would love to learn more about Anti-Age, but I want to actually talk about your background because it's truly impressive.
0:56
SPEAKER_00: I mean, you've worked across so many different fields, you know, dermatology, aesthetics, even the surgery side.
1:02
SPEAKER_00: So if you could kind of tell us about your background and your career, just so we have an understanding of where you're coming from.
1:08
SPEAKER_01: Yes, I was very fortunate.
1:09
SPEAKER_01: I've been in the aesthetic industry for over 19 years now.
1:12
SPEAKER_01: I started working first in plastic and reconstructive surgery.
1:16
SPEAKER_01: And uh once I felt like I had kind of reached where I had hit the limit, I wanted to be able to not only share what I knew with my patients, but also continue to expand my knowledge and be able to share it with other practices around the United States.
1:30
SPEAKER_01: So that naturally led me into aesthetic sales.
1:33
SPEAKER_01: I've been very fortunate to work for some of the top aesthetic companies like Skin Suiticals, Mersneo Cutis, Zio Skin Health.
1:39
SPEAKER_01: And now I'm beyond really honored to work with Antioch and lead our global education team.
1:45
SPEAKER_00: That's pretty cool.
1:46
SPEAKER_00: You worked with a lot of great brands.
1:47
SPEAKER_00: I love those brands.
1:49
SPEAKER_01: Oh, yes.
1:50
SPEAKER_01: But when I first started in aesthetics, the thing that I always think is kind of funny is it really was when the injectable era had just begun.
2:01
SPEAKER_01: And I like so far as remembering, like being blending in lidocaine with different injectables, because they didn't exist yet.
2:08
SPEAKER_01: So I've been in this industry for quite some time.
2:11
SPEAKER_01: Patients were so discreet back then that you literally had an exit out of the back building because people didn't want to run into anybody after they'd had something done.
2:20
SPEAKER_01: Well, now we're in this beautiful place where we fast-forward into where people are proudly tagging their injectors and aestheticians.
2:27
SPEAKER_01: And it's not just a new ball game, it's like a completely new sport.
2:31
SPEAKER_01: And I absolutely love it because that cultural shift, in my opinion, towards transparency has absolutely fueled innovation.
2:39
SPEAKER_01: And even as the technology advanced, I kept noticing some of those clinical gaps where we were just kind of treating the symptoms of aging and volume loss, laxity, those fine lines without actually supporting the skin's underlying biology.
2:52
SPEAKER_01: So, you know, we could burn it off, we could fill it.
2:55
SPEAKER_01: And I think we've all kind of seen the ramifications of that with the pillow face people from the 90s and early 2000s.
3:02
SPEAKER_01: But now we really are moving into a softer, more natural-looking era.
3:07
SPEAKER_01: And I think that's really what's beautiful about regeneration.
3:11
SPEAKER_01: Uh, I was always a huge supporter of sculptruff when my patients would come in, and it's because it really stimulated collagen production and offered that regenerative benefit.
3:20
SPEAKER_01: So when I came essentially aware of the different science behind the advanced stem cell growth factors and exosomes, everything just kind of clicked for me.
3:29
SPEAKER_01: It was like a natural evolution of my career.
3:31
SPEAKER_01: I moved from, you know, just simply managing the appearances of aging to actually influencing the way that tissue behaved in a cellular level.
3:39
SPEAKER_00: Yeah, no, that's really fascinating though, because you're bringing forward something I'm very passionate about, which is regenerative medicine.
3:44
SPEAKER_00: You know, I think that we've definitely seen the realm of like, obviously in the aesthetic space it's different, but even in the skincare space, we've seen this huge influence lately is, you know, with uh regards to regenerative medicine.
3:56
SPEAKER_00: And it really makes you wonder, you know, how much can we really bring over, right?
4:00
SPEAKER_00: Without having these invasive techniques or, you know, these procedures.
4:04
SPEAKER_00: And so I'm I'm curious if you could kind of define this for us, because you know, the term is being used everywhere right now, but in in your view, what truly is regenerative skincare versus just like reparative or anti-aging?
4:18
SPEAKER_01: It's such a good question.
4:19
SPEAKER_01: Because I I completely agree with you.
4:21
SPEAKER_01: The term regenerative is definitely having a moment.
4:24
SPEAKER_01: Uh, it's kind of like a, you know, a decade ago it was everything was authentic.
4:28
SPEAKER_01: Now it's everything's regenerative, but it it really is everywhere now.
4:32
SPEAKER_01: And I think it's important, as you say, that we really clearly define, especially in the context of aesthetics and skincare.
4:38
SPEAKER_01: Uh to me, regenerative skincare product is one that supports the skin's natural processes.
4:43
SPEAKER_01: It's helping to optimize the way the skin functions, maintains its balance, and appears more youthful and resilient over time.
4:50
SPEAKER_01: It's very different, in my opinion, from reparative, which often in my mind, what I used to work with in different companies, a lot of it had to do with soothing the skin, comforting the skin, especially if it was in a stressed state, maybe even helping with anti-aging, with different things that could have some temporary tightening.
5:08
SPEAKER_01: But in regenerative aesthetics, we focus on encouraging the skin to function more like it did when it was its healthiest, most vibrant.
5:16
SPEAKER_01: So that's where biosignals like growth factors and exosomes really come into play.
5:21
SPEAKER_01: And these aren't just trendy ingredients, although there is a buzz around them, they're our body's natural messengers.
5:27
SPEAKER_01: Our skin naturally recognizes them and they help to promote that balance, refreshed look to the skin.
5:33
SPEAKER_01: And that's really why I was drawn to Antiage.
5:35
SPEAKER_01: The brand is built on real science, not just buzzwords.
5:38
SPEAKER_01: Our topical formulations feature growth factors and cytokines derived from bone marrow.
5:43
SPEAKER_01: We're currently the only company that focuses on that.
5:46
SPEAKER_01: And what we found is it really helps the skin to look and feel more revitalized.
5:50
SPEAKER_01: And then when you pair that with the other evidence-based ingredients, it complements the skin's natural renewal process.
5:56
SPEAKER_00: Yeah, that's really fascinating, actually, because we hear a lot about, you know, there's different sources for exosomes, right?
6:03
SPEAKER_00: And there's different people use a lot of plant-based exosomes.
6:06
SPEAKER_00: I mean, I'm I'm just curious what your opinion around that is.
6:09
SPEAKER_00: Do you think that we should be doing that, or do you think there's efficacy there, or is it really important to stick to this more like, you know, um human model?
6:18
SPEAKER_01: Uh I love that you brought that up.
6:20
SPEAKER_01: Uh so I'm very Southern, if you can't tell from my voice, but I always use the the saying that I never call anybody's baby ugly.
6:28
SPEAKER_01: There are benefits to other uh stem cell choices that are out there with plant stem cells, though, the way I explain it is it doesn't have the same level of cell-to-cell communication that a human-derived exosome or say a recumbent human-derived exosome will.
6:43
SPEAKER_01: If you've ever tried to speak to someone who spoke a different language than you, you may be able to work it out over time, but it doesn't have the quick level of communication to be as beneficial as it could be.
6:54
SPEAKER_01: That's where I really do believe that human-derived exosome or where we've created our biosome technology with recumbent exosomes is really the next generation of what we should look forward to.
7:05
SPEAKER_00: Yeah, it's very interesting to me as well.
7:07
SPEAKER_00: For the exact reasons you described, I mean, I always wonder about the biocompatibility when we're coming from plants over to human tissue.
7:14
SPEAKER_00: It's always a big question mark.
7:15
SPEAKER_00: So thank you for explaining that.
7:17
SPEAKER_00: I and I'm curious, you know, what are biosomes?
7:19
SPEAKER_00: What exactly are those?
7:20
SPEAKER_00: Yeah.
7:21
SPEAKER_01: So biosomes were created by Celeste, our mother company.
7:24
SPEAKER_01: So they are proprietary to antiage, and we consider them truly a first of its kind.
7:29
SPEAKER_01: There are a lot of different delivery technologies that are out there: liposomes, oleosomes.
7:35
SPEAKER_01: But what's unique about biosomes is they are designed to mimic the exosome function.
7:42
SPEAKER_01: So when we looked at our exosomes, just full transparent, we're a global company, and in some areas they don't allow a human-based exosome.
7:49
SPEAKER_01: And we didn't want to shortcut our accounts that are in those global markets.
7:54
SPEAKER_01: And I'm so grateful to work for Dr.
7:56
SPEAKER_01: Chi Zhang and Dr.
7:57
SPEAKER_01: Rob Knight.
7:57
SPEAKER_01: They were such brilliant scientists.
7:59
SPEAKER_01: They were able to really take what they had learned from decades of recumbent growth factor technology and advanced lipid chemistry and create these really unique biomimetic exosomes.
8:10
SPEAKER_01: So they looked at what the key functional proteins, lipids, and those additional features that made exosomes so great at what they did.
8:18
SPEAKER_01: But what they found and what we all know is exosomes contain many components that aren't actually functional for aesthetics.
8:24
SPEAKER_01: They weren't secreted from cells with the main purpose of aesthetics, right?
8:28
SPEAKER_01: They had a function for what they were doing in the body.
8:30
SPEAKER_01: With biosomes, we really aim to remove that non-functional component and produce nanoparticles that contain only those beneficial functional growth factors.
8:40
SPEAKER_01: And we came up with a combination of growth factors that really replicate the function of our stem cell-derived exosomes.
8:46
SPEAKER_01: So, in my opinion, other delivery systems truly are amazing.
8:50
SPEAKER_01: There are some really great ones out there, but biosomes are biomimetic exosomes.
8:55
SPEAKER_01: They don't just deliver, they really speak the skin's language.
8:58
SPEAKER_00: It makes sense.
8:59
SPEAKER_00: So, what is the value of encapsulating exosomes?
9:02
SPEAKER_00: I think for our listeners, it would be great to dive into that and like the purpose of encapsulation.
9:08
SPEAKER_01: Absolutely.
9:09
SPEAKER_01: So when we talk about encapsulating those biomimetic exosomes, we're allowing for better stability.
9:14
SPEAKER_01: So that could be everything from just better stability so that when it's combined into a skincare emulsion with a multitude of different ingredients, that it's able to maintain its integrity.
9:24
SPEAKER_01: It's also very good when we're talking about things like transportation.
9:28
SPEAKER_01: You know, it has to get from our lab to your location and being able to make sure that it maintains its integrity.
9:34
SPEAKER_01: Human-based exosomes, they're naturally very delicate ladies.
9:39
SPEAKER_01: So with them, they they can break down very easily if they're not in the right temperature, if they don't have the right stability.
9:45
SPEAKER_01: And by creating that really unique lipid shell that we create with our biosomes, we're able to really stand up against those issues and elements.
9:54
SPEAKER_00: Yeah, it makes sense actually.
9:56
SPEAKER_00: I've always um, you know, I think one of the biggest things with exosomes was for me when I first heard about them was the idea of like these are gonna go anywhere.
10:04
SPEAKER_00: You know, there's not a it without having some something to anchor them, right?
10:08
SPEAKER_00: Or like to target them to specific tissues, it's very difficult because they can go into the CNS and they're nano.
10:15
SPEAKER_00: So for everyone listening, you know, nano-sized anything can go as deep as it it is allowed to go in the human body.
10:21
SPEAKER_00: It's very, very deep tissue.
10:22
SPEAKER_00: So I think it's very important to learn about how these technologies are actually being used in a way that they're not going to cause that kind of damage, you know.
10:30
SPEAKER_00: So I think encapsulation is very important in that way, right?
10:33
SPEAKER_00: So I'm very curious about how, you know, you guys are using the exosomes when it comes to skincare, because this is a conversation I've seen a lot on social media right now.
10:42
SPEAKER_00: It's like people are wondering, you know, exosomes should be stored at like negative 80, right?
10:46
SPEAKER_00: And they're they're frozen.
10:48
SPEAKER_00: So when you bring them out of that, you know, there's a lot of talk around they get damaged, the membranes get damaged, the viability is not intact.
10:57
SPEAKER_00: So can you talk to us a little bit about this process that those exosomes are going through before they're being packaged into you know skincare products?
11:06
SPEAKER_01: Sure.
11:06
SPEAKER_01: So one of the things that we do that's a little bit unique compared to some of the other brands, which you know, that's just that way that it is, is we use lyophyllization.
11:17
SPEAKER_01: So lyophilization with our exosomes, with our biosomes, allows it to have, of course, that maintainability with our presentation inside the skincare products.
11:28
SPEAKER_01: Now, our lab team, because they created that shell, again, going back to being able to protect the shell, we're able to create it in a way that it maintains that stability within the temperature for two-year shelf life.
11:40
SPEAKER_01: So the formulation of it in the solution is going to be very different compared to the form the way that it was created for our skincare model.
11:49
SPEAKER_01: That's something that is very difficult to do.
11:52
SPEAKER_01: When we're talking about our skincare, of course, it's very, as I mentioned, difficult to put a human-based exosome into a product and it maintain that stability.
12:01
SPEAKER_01: So because we were able to create it, we're able to maintain that stability as opposed to a human-derived exosome that has the potential of breaking down with temperature, with interaction with other ingredients.
12:13
SPEAKER_00: Interesting.
12:14
SPEAKER_00: So, how do you quantify the number of viable exosomes in your formulations from theory to finished product?
12:20
SPEAKER_01: Oh, yes, such a great question.
12:22
SPEAKER_01: We could ask this a lot.
12:23
SPEAKER_01: So, with lyophilization, as you know, that's a freeze-drying process.
12:27
SPEAKER_01: Uh, we essentially water is removed from each vial by freezing it, lowering that surrounding air pressure, and then allowing that frozen water to sublimate or turn from a solid to a gas.
12:37
SPEAKER_01: Now, most people, when they think about this, of course, they the concept of it has kind of had some back and forth lately with it can damage exosomes, and it can if it's not done properly.
12:50
SPEAKER_01: The process can damage some biological materials.
12:52
SPEAKER_01: So we underwent a period of extensive process of development to optimize those parameters and include the cryoprotectant traile.
13:01
SPEAKER_01: So there's some really great published studies.
13:03
SPEAKER_01: One was from the International Journal of Pharmaceuticals in 2018 about the preservation of exosomes with traol A's, specifically because of needing that ability to transport.
13:15
SPEAKER_01: Now, knowing that, you know, we really wanted to be able to prove that we have intact exosomes that maintain their stability, to maintain their integrity.
13:24
SPEAKER_01: You know, we began our research and development in exosomes in 2016.
13:28
SPEAKER_01: You know, most people didn't start hearing the buzz about exosomes until around 2020, 2021.
13:34
SPEAKER_01: But we've known as far back as 2011 that we had exosomes in our cell cultures, but we also knew we had to have the right lab team in place and the right technology to create those intact exosomes.
13:45
SPEAKER_01: Now, we launched our first exosome in 2023.
13:48
SPEAKER_01: So where there's a lot of companies that are kind of jumping on the trend, we spent over seven years developing it and getting it right.
13:54
SPEAKER_01: We do a ton of testing on the final product to ensure that that exosome integrity is functioning and we're really delivering something that is stable.
14:04
SPEAKER_01: Each batch first undergoes nanoparticle tracking analysis.
14:07
SPEAKER_01: This basically tells us how many particles are present, but it doesn't tell us if those particles are exosomes.
14:13
SPEAKER_01: So nanocyte is an example of this.
14:15
SPEAKER_01: And many of our competitors really end things here.
14:18
SPEAKER_01: They don't do any additional testing, but at this point, you only really know that you have small things.
14:23
SPEAKER_01: You don't know what the small things are.
14:24
SPEAKER_01: So the next step that we do is we do nanoflow cytometry.
14:29
SPEAKER_01: This gives us some more information on what exactly those small particles are and what percentage of those are exosomes.
14:36
SPEAKER_01: We stain our sample with a dye that binds to lipids.
14:39
SPEAKER_01: We kind of talked about exosomes and biosomes have that telltale lipid bilayer, and we can stain for it and measure it.
14:46
SPEAKER_01: So once we know how many total particles we have and how many of them have that lipid bilayer, we then image those particles using super resolution microscopy.
14:55
SPEAKER_01: This allows us to really confirm membrane integrity so we know that lyophilization hasn't damaged the particles, but it also lets us stain and count the number of tetraspanins present in each individual exosome.
15:08
SPEAKER_01: So doing this on every batch means we're able to quickly identify any differences between the exosome batches and ensure we have a quality and consistent production with little batch to batch variation.
15:20
SPEAKER_01: So once we've characterized the exosomes, we know we have exosomes in the product.
15:25
SPEAKER_01: Each batch goes through that in vitro testing.
15:28
SPEAKER_01: So we just continue to check boxes all the way down.
15:31
SPEAKER_01: We treat the human skin cells with exosomes and measure how they alter the expressions of specific genes in those cells.
15:38
SPEAKER_01: We look at changes in the extracellular matrix, so things like collagen elastin, as well as that anti-inflammatory response in the exosomes.
15:46
SPEAKER_01: So we do all of this, and we do all of this because we invested in research and development.
15:52
SPEAKER_01: In our lab, we have a 35,000 square foot research and development lab in Irvine, California.
15:57
SPEAKER_01: Everything that we produce is produced by our lab team and is done in-house.
16:02
SPEAKER_01: So we're able to have complete control of our finished product.
16:05
SPEAKER_01: All these little checks and balances aren't possible for companies who, for instance, don't own their own lab, have someone else creating their own product, or they don't have the tools that we've invested in.
16:15
SPEAKER_00: Yeah, no, this is really fascinating for me that you have this capacity to do it in-house because that, you know, some of these questions, like for a lot of the listeners out there, you guys, this might sound very technical, but it's really very key questions that you should be asking and wondering about when it comes to exosome-based skincare in general, you know, because if you're if you're buying something and there hasn't been all of this testing done to ensure that the final product that's in your hand, like as a as a product, doesn't have this kind of testing behind it where, you know, you know the amount of particles in there, you know exactly, you know, that they're they're viable, they're still intact, like then they're you're not gonna see any kind of results.
16:54
SPEAKER_00: So I'm just like clarifying for our listeners, you know, why we're diving so deep, because I think this is a this is the next generation of the conversation that needs to take place, you know.
17:02
SPEAKER_00: I think around any kind of nanotechnology, and you know, especially when you're bringing it over to the skincare or OTC space for people to actually consume and utilize on a day-to-day basis.
17:13
SPEAKER_00: I think they need to be able to understand this stuff.
17:15
SPEAKER_00: So that's very cool that you guys have all of this done and you're doing your homework so thoroughly, and it's within house.
17:20
SPEAKER_00: That's huge.
17:22
SPEAKER_00: Yeah.
17:22
SPEAKER_00: So I want to talk about there's some concerns in medical literature, right?
17:26
SPEAKER_00: And I kind of touched on this earlier when it comes to you know crossing the blood-brain barrier.
17:31
SPEAKER_00: This is a big problem, you know, that we're seeing with nanotechnology in general.
17:36
SPEAKER_00: How do you address those claims?
17:38
SPEAKER_00: And how does encapsulation actually work when it comes to mitigating that kind of risk?
17:43
SPEAKER_01: Yeah, so you know, we sell a topical exosome product.
17:46
SPEAKER_01: So when applied topically with exosomes, we typically are not going to see a systemic circulation.
17:51
SPEAKER_01: But with the encapsulation that we have, it gives it a very specific engineering so that the focus remains in those skin cells.
18:00
SPEAKER_01: So there's a a lot of really interesting technology that's starting to emerge about being able to utilize exosomes really in the medical space for delivery for things like Alzheimer's and cancer and things of this nature.
18:13
SPEAKER_01: But we definitely stick in our arena with topical aesthetics and focused on that epidermis and dermis.
18:19
SPEAKER_00: So, what is the load of the amount of these of the exosomes in the product?
18:24
SPEAKER_00: Like how much are you delivering per use?
18:27
SPEAKER_01: Yeah.
18:27
SPEAKER_01: So with each of our uh solutions, you're getting 10 billion exosomes.
18:32
SPEAKER_01: With the biosomes, you're getting 25 billion of those biosomes.
18:36
SPEAKER_01: So they're meant to be alternatives to each other, not necessarily competitors to each other.
18:42
SPEAKER_01: So it's really a matter, in my opinion, when selecting whichever product you prefer, a lot of it has to do with the practitioner's preference, or it has to do with that patient's preference.
18:54
SPEAKER_01: So if you have someone, let's say, for instance, is wanting something that is more refined, that only contains, you know, kind of tried and true known recumbent growth factors, I would recommend, especially from a non-human source, to utilize our biosomes.
19:08
SPEAKER_01: If there's someone who is, you know, that's really not a concern for them, then our traditional exosomes would be the way to go.
19:16
SPEAKER_00: Interesting.
19:16
SPEAKER_00: I would love for you to speak on the sourcing of the stem cell derived biosignals.
19:22
SPEAKER_00: I mean, how does donor selection, lab conditions, purification, all of that, how does it affect the safety and potency of the final products?
19:30
SPEAKER_01: Oh my gosh, it is it is incredibly important.
19:33
SPEAKER_01: Safety is one of the biggest things for me, and especially for our lab team.
19:37
SPEAKER_01: At the end of the day, we're wanting to improve people's lives and we're wanting to make sure that we deliver the safest, most potent product possible.
19:45
SPEAKER_01: So all of our donations came from an FDA-cleared third-party proprietary biolab.
19:50
SPEAKER_01: They, that is what they do.
19:52
SPEAKER_01: So they collect donations for different hospital groups as well as clinical trials.
19:57
SPEAKER_01: That is their arena.
19:58
SPEAKER_01: So they have to adhere to all FDA recommended guidelines for tissue donation.
20:03
SPEAKER_01: They go through an extensive healthcare questionnaire with the donors.
20:06
SPEAKER_01: They test them for 20 different viral and bacterial markers, and this is all before they're ever admitted into the donor program.
20:13
SPEAKER_01: We select females between the ages of 18 and 24, healthy, athletic.
20:18
SPEAKER_01: And with those parameters set, we select the best of the best out of that.
20:23
SPEAKER_01: So those that have the highest cytokine profile.
20:26
SPEAKER_01: Health and age of the donor is incredibly important.
20:29
SPEAKER_01: When we think of aging, we know around the mid-20s to late 20s, that's when we start to see that drop-off of collagen.
20:36
SPEAKER_01: The 30s, we start to see that drop-off, pretty significant drop-off in elastin.
20:41
SPEAKER_01: So by selecting those healthy athletic women in their prime, we're able really to provide a nice robust product.
20:48
SPEAKER_01: But most importantly, we have GMP cells or good manufacturing practice cells.
20:53
SPEAKER_01: We have to maintain the strictest conditions set forth by regulatory agencies.
20:58
SPEAKER_01: And we've created a master and working cell bank.
21:01
SPEAKER_01: So we have access to the same cells for at least the next seven years.
21:04
SPEAKER_01: And very few companies actually own their own cell bank.
21:08
SPEAKER_01: Our lab is also GMP and ISO certified.
21:10
SPEAKER_01: It essentially means we adhere to those highest manufacturing standards, not only on a national level here in the US, but also on an international level.
21:19
SPEAKER_01: So we're registered with the FDA under the new MOCRA guidelines for cosmetic indication.
21:24
SPEAKER_01: So every product we have and our lab is registered with the FDA for topical cosmetic and complete compliance with MOCRA.
21:31
SPEAKER_00: Wow, that's that's really great to hear that because there's a lot of fuzziness, I think, out here right now with the biotechnology we're seeing, you know, in skincare.
21:39
SPEAKER_00: It's something I worry about because I feel like we're shifting from like that clean skincare trend to now we want this very tech heavy kind of innovation in our skincare products.
21:49
SPEAKER_00: But then, you know, that's exactly it.
21:51
SPEAKER_00: Like we don't know a lot of the the regulatory stuff that goes around this, right?
21:55
SPEAKER_00: Like there's not a lot of uh transparency there.
21:58
SPEAKER_00: But I think that that's where you guys really should.
22:00
SPEAKER_00: For me, you know, as a brand is that you're you're very clear about what you're doing and and how this works.
22:06
SPEAKER_00: And I think for consumers, it's very important for us to be able to see kind of that backdoor kind of view, right?
22:11
SPEAKER_00: Of like what are brands doing?
22:13
SPEAKER_00: How does all of this work?
22:14
SPEAKER_00: How do you really bring over something like true regenerative medicine into this scope and then be able to verify that it's actually going to work?
22:22
SPEAKER_00: So with that in mind, I want to actually ask you a little bit about any trials that you guys have done or any of the data that you've collected with regards to the results that we can expect from the products, anything that you can speak to.
22:34
SPEAKER_01: Yeah.
22:34
SPEAKER_01: So we actually have a multitude of clinical studies and white papers that really go into not only the characterization and description of what those exosomes are, as far as the entire policy from start to finish, how they're created, same with our biosomes and our growth factor solutions.
22:52
SPEAKER_01: But we also have a white paper that's specifically on our safety and manufacturing.
22:56
SPEAKER_01: Dr.
22:56
SPEAKER_01: Rob Knight, our lead scientist, he actually has his PhD in small extracellular vesicles as anti-scarring therapeutics or what we know is exosomes.
23:05
SPEAKER_01: We're currently the only aesthetic company that I know of that has someone who has their field of study literally leading that team for aesthetics in exosome arena.
23:15
SPEAKER_01: His goal is to really set the standard for exosomes, the way that they're manufactured and the way that we bring a product to market.
23:23
SPEAKER_01: So it's very important to us that we are very transparent and give our science to our practitioners as well as anyone who's interested in learning about it so that they know how much time, care, and safety we put into place.
23:36
SPEAKER_00: Yeah, that's that's fascinating.
23:38
SPEAKER_00: I mean, I think for me, I'm very, very curious about what this generation of like skin health products means for consumers.
23:46
SPEAKER_00: You know, I know a lot of times when we talk about skincare, it's we're very anti-aging, right?
23:52
SPEAKER_00: Like that's the that's the focus everybody seems to have is like wrinkles, elasticity, you know, firmness of the skin.
23:58
SPEAKER_00: But I think when I when I look at something like this, it's also from this preventative lens as well, where this could become our preventative everyday routine that we're utilizing, say in our late 20s, right?
24:10
SPEAKER_00: Going forward.
24:11
SPEAKER_00: And then, you know, what do you feel about that in terms of like how we should be positioning of these kind of options in the skincare space when consumers are looking for for like maintenance kind of skincare?
24:22
SPEAKER_01: I I so appreciate that you said that.
24:25
SPEAKER_01: I the plastic surgeon that I work for, Dr.
24:27
SPEAKER_01: Alexander DeGennis uh in Louisville, Kentucky, he was brilliant because his goal was always prevention before correction.
24:34
SPEAKER_01: And it was in a time when that wasn't something that was really talked about.
24:38
SPEAKER_01: So when we're talking about prevention, just getting people started on the basics and really being able to protect their skin from that environmental assault from different types of antioxidants, as well as strengthening that skin barrier, all the way up to really helping to restore the skin into proper function if they do have dysfunctional skin.
24:58
SPEAKER_01: Where we're seeing a lot of breakdown, of course, are things like uh we're talking about inflammation, chronic inflammation that causes premature signs of aging.
25:06
SPEAKER_01: And also just in general, not being able to provide people with products that have ingredients that aren't working against them.
25:12
SPEAKER_01: Uh and I would do any type of skin consult.
25:15
SPEAKER_01: A lot of the problems that I was seeing were because people weren't selecting products that were correct for their skin.
25:20
SPEAKER_01: And what I love about Antiage is we really truly have created a line that can be used on any skin type.
25:26
SPEAKER_01: It really is a very targeted and complete line that's very simplistic in its approach.
25:34
SPEAKER_00: I love that.
25:34
SPEAKER_00: I think we need more of that, you know, because everything is so focused on like, well, you know, we're gonna just get rid of every wrinkle on your face, you know, and we're just gonna, it's like very like it becomes too much in the skincare space sometimes because everybody's so hyper-focused on this whole idea of like, no, you know, we want to completely eradicate all pores and like let's get rid of every sign of wear and tear.
25:57
SPEAKER_00: I think it the idea of regenerative medicine for me is that you are promoting health more than anything, right?
26:03
SPEAKER_00: It's like if you're looking at the skin overall, and this is for everyone listening, if you guys are looking at your skin, your goal should be what can I do that's going to every day maintain its integrity so that it can fight off what it's supposed to fight off?
26:17
SPEAKER_00: Like that's the skin's purpose as an organ.
26:19
SPEAKER_00: So when we look at skincare products, I get very baffled when I see everybody using crazy, you know, exfoliation ingredients and everyone's got like 15 AHAs and you know, their product and whatever.
26:30
SPEAKER_00: It's just nonsense to me at this point because you're damaging your skin and you're you're actually stripping from it the purpose that it serves, which is true protection of everything else that's on the inside.
26:41
SPEAKER_00: So I'm I'm very, very curious about where this is gonna go in the future, like how people will approach skincare.
26:47
SPEAKER_00: So I want to talk a little bit about in terms of like really utilizing the products, like in conjunction with some of the procedures that we might want to opt in for, like microneedling or lasers.
26:57
SPEAKER_00: Can you speak to us a little bit about that?
26:59
SPEAKER_00: Like, where does the skincare line really fit in when it comes to, you know, obviously maintenance, but then also working in conjunction with these other kinds of things that we want to opt in for in a space?
27:09
SPEAKER_00: Yes, yeah.
27:10
SPEAKER_01: So we really see antiage capable of being used everywhere, from daily skincare routines to the treatment room.
27:17
SPEAKER_01: The flexibility is part of what makes it so powerful.
27:20
SPEAKER_01: It's one of my favorite things to talk about because the versatility of antiage is really where the innovation shines.
27:26
SPEAKER_01: Our products are designed to be incredibly adaptive.
27:29
SPEAKER_01: So the provider can really use them as both a standalone topical for daily skin optimization and as powerful adjuncts to in-office procedures.
27:38
SPEAKER_01: We're seeing, of course, more advanced procedures or providers really incorporating them with different procedures, like our exosome solutions after fractional lasers, radio frequency microneedling, or even deeper resurfacing treatments.
27:50
SPEAKER_01: You know, but we really have a full portfolio of products.
27:53
SPEAKER_01: So we fall into three major categories for our solutions with rejuvenation, brightening, and hair.
27:59
SPEAKER_01: So you can really customize that treatment plan in a very precise way to optimize those patient outcomes, whether it's pairing our brightening exosome or biosome with things like your IPLs, your BBLs, your MOXIs, your treatments that are focused on unwanted discoloration.
28:15
SPEAKER_01: With rejuvenation, you know, really being able to provide that patient with something to calm that skin after they've had the treatment while also enhancing it and getting them back into life faster.
28:26
SPEAKER_01: No one wants to spend their two weeks of hard-earned vacation hiding out at home while they heal.
28:32
SPEAKER_01: I mean, so that's that's no fun.
28:35
SPEAKER_01: So we want to make sure that the experience is more comfortable for them while we're also really enhancing those results.
28:41
SPEAKER_01: Now, I love treatment stacking, but as you know, the more energy we deliver into the skin, the more injury we can cause, the more chances we have for damage.
28:50
SPEAKER_01: So properly pre-treating skin is so paramount.
28:54
SPEAKER_01: It was such a non-negotiable for me in my practice.
28:57
SPEAKER_01: You know, it's an extension of the treatment in my plan in my mind.
29:01
SPEAKER_01: Skincare is an extension of the treatment.
29:03
SPEAKER_01: I give the analogy that you never sign up for a marathon and then just show up on the day of the race.
29:08
SPEAKER_01: Your body needs to be conditioned.
29:11
SPEAKER_01: It's the same with our skin.
29:12
SPEAKER_01: We have to prepare the skin for major treatments that we're about to put it through.
29:17
SPEAKER_01: And it never fails.
29:18
SPEAKER_01: It's always that patient that comes in with the red face and the compromise barrier with severe signs of aging that wants you to just bust out the big guns.
29:25
SPEAKER_01: Yeah.
29:26
SPEAKER_01: But we know the best results are not going to happen until we get that skin in a good place, until we have it restored, that barrier protected, and in that good place.
29:36
SPEAKER_01: And that's really where we're able to shine.
29:39
SPEAKER_01: You know, our home care is really unique.
29:41
SPEAKER_01: It can be used to pre-treat the skin in advance.
29:44
SPEAKER_01: It can be the post-procedure product that you get for those days after the treatment.
29:49
SPEAKER_01: And it's also your daily skin care.
29:51
SPEAKER_01: So most people know antiage for our treatment solutions, but we have that same innovation as I mentioned in our home care.
29:58
SPEAKER_01: We feature that proprietary biosome technology.
30:02
SPEAKER_01: And as we've talked about, most people don't realize how incredibly fragile, you know, a traditional human-derived exosome is.
30:09
SPEAKER_01: Breaks down really easy in the formulations, but our lab team really did lead the way.
30:13
SPEAKER_01: Exosomes are powerful but fragile.
30:16
SPEAKER_01: And that's why biosome technology is such a game changer for stability and performance.
30:21
SPEAKER_01: And they develop biosomes as a specialized delivery system to protect to preserve those delicate biosignals, ensuring that they stay intact.
30:28
SPEAKER_01: And that's part of the reason our home care products perform so well.
30:32
SPEAKER_01: And not just after procedures, but as part of a long-term skin health strategy.
30:36
SPEAKER_01: It also makes it really easy for your patients as well.
30:39
SPEAKER_01: All of us have probably experienced trying to sell a patient on what we think is the perfect protocol with 20 steps, but very hard to get someone to commit to that amount of products.
30:50
SPEAKER_01: I call it the shelf of shame, all the products that they purchased that they're not actually using.
30:55
SPEAKER_01: We're able to really give them all of the nutrients and the ingredients that are necessary for skin improvement without the need of a multitude of extensive serums that are just going to sit there.
31:07
SPEAKER_01: So when I think of the ways that we can improve the skin, it really is our system is two products.
31:12
SPEAKER_01: It provides your patients with everything that they need, those antioxidants, growth factors, peptides, barrier and microbiome support, and it eliminates the needs for multiple products.
31:22
SPEAKER_01: So great for those busy moms, great for gentlemen that like to keep things simple.
31:27
SPEAKER_01: But I mean, we're all bound by our financial limitations.
31:30
SPEAKER_01: So it's also a great way to prevent them from ordering a bunch of products that they don't need.
31:35
SPEAKER_01: And this is something you know is going to deliver what it says it's going to deliver.
31:38
SPEAKER_01: So whether it's pre-treating the skin or post-procedure, you know, support, uh, daily rejuvenation, anti-Ouch really gives providers a science-backed, flexible system that they can trust.
31:49
SPEAKER_01: And then patients actually see results from.
31:52
SPEAKER_00: Yeah, it's really fascinating because a lot of the ingredients, right?
31:56
SPEAKER_00: Like I, for example, like peptides are huge right now.
31:58
SPEAKER_00: I think everybody's got a big question mark over their head when it comes to peptides because, you know, everyone's talking about it.
32:04
SPEAKER_00: Like all of the all of the companies are talking about peptides.
32:07
SPEAKER_00: But then this is where, you know, I think this kind of technology, you know, using exosomes becomes very, very relevant is the idea of like if you're applying something like peptides on topically, you want to actually make sure they're going where they're supposed to go, right?
32:21
SPEAKER_00: And they're actually signaling the way they should be signaling to make your cells respond.
32:25
SPEAKER_00: So can you speak to us a little bit about that?
32:27
SPEAKER_00: You know, just to kind of debunk some of the myths maybe that are out there about, oh, you know, every peptide product is the same or every brightening product is the same.
32:34
SPEAKER_00: And and how does this really apply when you're looking at utilizing something like the, you know, the biosome technology you guys have created and enhancing the effects that we can see?
32:44
SPEAKER_01: Oh, absolutely.
32:44
SPEAKER_01: So when we talk about skin care, I always kind of joke when we see the commercials on TV, there's a 20-year-old that says, you know, it was talking about wrinkle removal and how it helped their skin.
32:54
SPEAKER_01: And it's just not factual, right?
32:56
SPEAKER_01: And there's a lot of different claims that are out there for what different peptides can do.
33:00
SPEAKER_01: There are some peptides that can do remarkable things, and then there are some that aren't even going to be able to penetrate through the barrier of the skin.
33:07
SPEAKER_01: And that's what's unique about biosomes, is we really have created, again, that nanoparticle technology that is able to penetrate into the skin and is able to facilitate these benefits to the skin.
33:18
SPEAKER_01: I'm a big believer in some of those major components, but I do feel like it gets bogged down in sensationalism because people are like, we have peptides.
33:27
SPEAKER_01: Okay, well, what peptides do you have?
33:29
SPEAKER_01: What is the function of those peptides?
33:30
SPEAKER_01: Is it actually benefiting the skin?
33:33
SPEAKER_01: And that's what we are really good about here at Antioch is not only saying that we have ingredients, but explaining what those ingredients do.
33:40
SPEAKER_01: We're such a very education and science-focused company.
33:43
SPEAKER_01: We want to make sure that not only do our practitioners understand the benefits of our products, but also going into detail with their patients in a way that they can understand as well.
33:53
SPEAKER_00: It's interesting.
33:54
SPEAKER_00: Yeah, no, I think you really hit it on the head of like you have to know what the peptides actually do and what their purpose is.
34:00
SPEAKER_00: I think in general, with ingredients, it's more of like we're, I think, past that phase of, okay, here's a bunch of stuff like growth factors, peptides that could actually theoretically work.
34:10
SPEAKER_00: I think we're past that, right?
34:12
SPEAKER_00: Where we now need to figure out now that we have this stuff and we have all these wonderful components figured out from the biotech side, how do we get this to the right place?
34:21
SPEAKER_00: How do we get the cells to respond to them?
34:23
SPEAKER_00: And that's that's the big question.
34:24
SPEAKER_00: So I would love to see consumers get to a point where we we're all starting to question that, you know, when we're approaching skincare, like, okay, cool, you have growth factors in your formula.
34:34
SPEAKER_00: Cool, you've got the peptides, but is this actually going to work on my skin?
34:37
SPEAKER_00: That kind of stuff.
34:38
SPEAKER_00: I'd love to see consumers start asking those deeper questions in a more cellular biology kind of realm, I guess.
34:44
SPEAKER_00: But no, this is this is really fascinating.
34:46
SPEAKER_00: I antiage is really, I think, very, very unique.
34:48
SPEAKER_00: I haven't really seen a brand like you guys.
34:50
SPEAKER_00: I've interviewed so many where the transparency is remarkable to me that you guys are able to speak about exactly what you're doing and how this works.
34:58
SPEAKER_00: I think this is really where I would love to see skincare go.
35:02
SPEAKER_00: Bring it to the people, like bring it put in people's hands to where you can use it daily.
35:07
SPEAKER_00: It's not just something available in a clinic or a med spa or wherever you're able to actually utilize it day in and day out and see results over time.
35:14
SPEAKER_00: So it's very fascinating and very exciting.
35:16
SPEAKER_01: Mm-hmm.
35:17
SPEAKER_00: Yeah.
35:18
SPEAKER_01: No, I uh one of the things I had the opportunity to just speaking about the importance of ingredients and how they function, I had the opportunity to train in some practices in Dubai and Abu Dhabi last year with our anti-olish Middle East team, who are just fantastic.
35:31
SPEAKER_01: But one of my favorite experiences of my career was really hearing their patients describe the changes that it had made in their skin and our products.
35:40
SPEAKER_01: So in aesthetics, we have these patients come to us and they tell us all the things that they hate about themselves when they look in the mirror.
35:46
SPEAKER_01: And we have the privilege of helping them restore that self-confidence.
35:50
SPEAKER_01: It's just such a beautiful thing.
35:52
SPEAKER_01: And it's it's amazing to me when people do take the time, whether it's the practitioners or the patients, to really ask the hard questions, to not just put something on their face, see it doesn't work, and just give up.
36:04
SPEAKER_01: And I am so proud of Antiage for really the, like you mentioned, the transparency, letting people know how our products work, why they work.
36:12
SPEAKER_01: Here's the, you know, giving them those details so that they can make those educated decisions and more importantly, so we can make those changes and really benefit them.
36:21
SPEAKER_00: Yeah, I and I want to actually ask you just for our consumers to understand, what are some of the main key, I guess, concerns that could be really targeted with the antiage products, you know, especially the ones that I think are maybe are the most popular in the line.
36:34
SPEAKER_01: Oh, yeah.
36:35
SPEAKER_01: So our core MD products are our system, which is our serum and accelerator, as well as our brightener.
36:42
SPEAKER_01: And what's beautiful about Antiage is we truly can be used on any skin type.
36:46
SPEAKER_01: We were designed to be used literally from the most sensitive of skin up to those that need the most correction.
36:52
SPEAKER_01: But there isn't going to be any peeling, flaking, and irritation, which is something that many of our practices look forward to.
37:00
SPEAKER_01: Although there are some benefits, of course, those more aggressive treatments.
37:03
SPEAKER_01: Not everybody wants to have their face fall off to see a result.
37:06
SPEAKER_01: So we've very thoughtfully put together this line so that we could create something that would make it easy for you as a practitioner to recommend.
37:16
SPEAKER_01: You know it can be used on anyone's skin because we're essentially delivering the ingredients that that skin needs to maintain its health.
37:24
SPEAKER_01: It's all about the skin's health.
37:26
SPEAKER_01: It's an organ like any other organ of our body.
37:28
SPEAKER_01: It's not vanity to take care of it, it's a necessity.
37:31
SPEAKER_01: And we're able to do that with our product.
37:33
SPEAKER_01: This is something, in my opinion, it's simple, it makes sense to our patients, and with simplicity comes compliance.
37:41
SPEAKER_00: Yeah, I'm really curious, and I'd love for you to kind of explain this to me because when we talk about the delivery, right?
37:48
SPEAKER_00: So exosomes are meant to help deliver some of these other ingredients, like peptides.
37:54
SPEAKER_00: How does that work?
37:55
SPEAKER_00: Because you're working with nanovesicles, but peptides are not nano.
38:00
SPEAKER_01: Yes.
38:01
SPEAKER_01: So what we are utilizing are actually recuminant growth factors inside of our actual biosomes.
38:08
SPEAKER_01: So those recombinant growth factors are designed to be created in smaller particles, and that's how we're able to do that.
38:15
SPEAKER_01: Now, the combination of other peptides within the formulation, we do have an encapsulation method that's more similar to what you expect with like a liposome delivery.
38:23
SPEAKER_01: So we do have encapsulation with our other ingredients, but the biosome itself is really what makes it unique with that growth factor.
38:31
SPEAKER_00: Okay.
38:31
SPEAKER_00: So it's mostly the growth factors that you're putting inside of the like you're encapsulating in.
38:36
SPEAKER_00: Okay, cool.
38:37
SPEAKER_00: Yeah, that makes that makes sense.
38:38
SPEAKER_00: So yeah, it's just fascinating, right?
38:40
SPEAKER_00: Because it's usually a cocktail of ingredients in there.
38:42
SPEAKER_00: So I'm just trying to figure out, you know, what gets delivered and how does that work.
38:45
SPEAKER_00: But yeah, very fascinating.
38:46
SPEAKER_00: I love it.
38:47
SPEAKER_00: I think what you're doing is really cool.
38:48
SPEAKER_00: You know, Antiage is really leading the way, it seems, in the space.
38:51
SPEAKER_00: Like I said, I haven't talked to many brands that are able to explain what exosomes actually do.
38:55
SPEAKER_00: And for all of our listeners out there, you know, if you guys have any more questions, I mean, I really I urge you to dig deeper into understanding how this kind of technology works.
39:03
SPEAKER_00: I think with nanovesicles in general, there's a lot of a lot of really heavy science that needs to be understood and understanding that these are very fragile, they're very, very fragile in nature.
39:14
SPEAKER_00: So when you're buying products, if somebody's making it for like, you know, 10 bucks, most likely it's not, it doesn't have it inside of it, you know.
39:21
SPEAKER_00: That's I'm sorry, but that's the hard truth.
39:23
SPEAKER_00: So we have to be very vigilant, I think, as consumers, when we're shopping for products that are actually gonna give us that efficacy that we're looking for.
39:30
SPEAKER_00: So if you guys are in the market for exosome-based products that are actually going to deliver what they're saying, you know, Auntie Ash is an excellent choice.
39:36
SPEAKER_00: Definitely check it out.
39:37
SPEAKER_00: But thank you so much.
39:38
SPEAKER_00: This has been such a lovely conversation.
39:40
SPEAKER_00: I've learned so much from you.
39:42
SPEAKER_01: Oh, thank you for having me.
39:43
SPEAKER_01: I really appreciate you letting us bring our conversation to you.
39:46
SPEAKER_00: Hey guys, so I hope you love that episode.
39:49
SPEAKER_00: Please make sure to hit subscribe if you're tuning in to us on any podcast platform.
39:54
SPEAKER_00: We are available on so many different platforms.
39:56
SPEAKER_00: So wherever it is that you're tuning in, just go hit subscribe.
40:00
SPEAKER_00: You will be immediately notified when we publish new episodes.
40:03
SPEAKER_00: This way, you're able to tune in to amazing insights from experts, brand founders, industry leaders, authors, all the wonderful people that we host.
40:11
SPEAKER_00: And that's very important for me because I love to hear from you guys and really understand what you love and what you want to hear more of.
40:18
SPEAKER_00: Also, make sure to give us a follow on all of our social media outlets.
40:22
SPEAKER_00: We're available on Instagram, TikTok, X, you name it, we're there.
40:26
SPEAKER_00: We also have a blog on Medium.
40:28
SPEAKER_00: So if you're a reader and you love Medium blogs, check us out on Medium.
40:32
SPEAKER_00: We publish some really great articles on there that do deeper dives than just what's available on the podcast.
40:37
SPEAKER_00: And it's really a great place for all of you science geeks out there that want to learn a little bit more.
40:42
SPEAKER_00: We go above and beyond with our research and making sure we're bringing you information that you usually probably won't hear about in other outlets.
40:49
SPEAKER_00: So check us out, leave us a comment, leave us a review, and we'll be back next time with another episode.
40:54
SPEAKER_00: Thank you.